The virtual meeting was held on April 23-25, 2021, where J&J featured a total of 13 posters and three oral presentations, including:
Presentation #26630: The Role of Skin Barrier in Cutaneous Adverse Drug Reactions in Oncology Therapy and the Benefit of Topical Emollients;
Presentation #26634: Insights into the Mechanisms of EGFRi-induced Cutaneous Adverse Drug Reactions From Functional Phospho-proteomic and Transcriptomic Data; and
Presentation #27031: Sunscreens Designed and Validated by Consumers to be Invisible on All Skin Tones. Sun protection including sunscreen is vital for everyone to protect their skin from sun damage and help prevent skin cancer,” said Barbara Green, senior director of skin health translational science at J&J. “However, a common misconception is that Black and Brown communities do not benefit from sunscreen. We formulated products specifically to be invisible on the skin while feeling weightless and breathable. She added J&J was pleased to prese